News Conference News PCR London Valves 2016 TAVR vs SAVR: Limitations and Risks Debated as Transcatheter Therapies Move Into Younger and Lower-Risk Patients Shelley Wood September 20, 2016
News Industry News Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) September 20, 2016
News Daily News Evolocumab Modifies IVUS-Detected Coronary Atherosclerosis: Topline Results From GLAGOV Michael O'Riordan September 20, 2016
News Daily News Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe Michael O'Riordan September 20, 2016
News Conference News PCR London Valves 2016 Leaflet Restriction After TAVR: Two Hospitals Tracking Patients Find Similar Rates of the Phenomenon Shelley Wood September 20, 2016
News Conference News PCR London Valves 2016 Innovation Overload? Too Many Novel Ideas May Be Holding Back Progress in Transcatheter Mitral Valve Technologies Shelley Wood September 19, 2016
News Conference News PCR London Valves 2016 MitraClip Feasible, Safe, and Produces Promising Early Results in Tricuspid Regurgitation Shelley Wood September 19, 2016
News Daily News Battle of the Brits: BMJ, Lancet Continue Sniping Over Statins Todd Neale September 19, 2016
News Industry News Edwards Sapien 3 Transcatheter Heart Valve Receives Expanded Indication In Europe September 19, 2016
News Opinion Fellow Talk How Should Fellows Learn From Live Cases? An Interview With Simon Redwood, MD Tiffany Patterson, MBBS September 19, 2016